NASDAQ:NAMS

NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus
····

NewAmsterdam Pharma Stock Rises as Fresh Filing Puts Its $4.3 Billion Drug Bet in Focus

NewAmsterdam Pharma shares rose 1.3% to $36.56 Wednesday after Chief Accounting Officer Louise Frederika Kooij exercised and sold 65,000 shares, according to a Form 4 filing. A separate Form 144 listed a proposed sale of 210,000 shares for Kooij. The company awaits key regulatory decisions on its cholesterol drug obicetrapib later this year. NewAmsterdam reported a first-quarter net loss of $48.4 million.
May 28, 2026

Stock Market Today

  • XRO and WTC Shares: Key ASX Stock Insights and Performance Analysis
    May 28, 2026, 4:40 PM EDT. Xero Ltd (ASX:XRO) and WiseTech Global Ltd (ASX:WTC) are notable Australian Securities Exchange stocks to watch. Since 2025, XRO shares have fallen 33.6%, while WTC shares are 70% below their 52-week high. Xero, a cloud-based accounting software leader, grew revenues by 26.4% annually to $1.7 billion in FY24 with a net profit rise from -$9 million to $175 million and a 14.3% return on equity (ROE). WiseTech, specializing in logistics software, reported revenue growth of 27.1% yearly to $1.04 billion with net profit up from $108 million to $263 million and a 12.8% ROE. These fundamentals reflect significant growth but require further valuation context for investing decisions.